Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 677583

Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms


Lenković, Maja; Stanić-Žgombić, Zrinka; Manestar Blažić, Teo; Brajac, ines; Periša, Darinka
Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms // Phlebolymphology, 19 (2012), 72-83 (podatak o recenziji nije dostupan, članak, stručni)


CROSBI ID: 677583 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms

Autori
Lenković, Maja ; Stanić-Žgombić, Zrinka ; Manestar Blažić, Teo ; Brajac, ines ; Periša, Darinka

Izvornik
Phlebolymphology (1286-0107) 19 (2012); 72-83

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
benefit; Daflon; chronic venous disease

Sažetak
Lower limb symptoms have frequently been associated with increased severity of venous disease. In clinical practice they are reported by patients at all stages of chronic venous disease. This study assessed the contribution of Daflon 500 mg in improving venous symptoms and promoting venous ulcer healing in patients with primary chronic venous disease.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Profili:

Avatar Url Teo Manestar Blažić (autor)

Avatar Url Maja Lenković (autor)

Avatar Url Ines Brajac (autor)


Citiraj ovu publikaciju:

Lenković, Maja; Stanić-Žgombić, Zrinka; Manestar Blažić, Teo; Brajac, ines; Periša, Darinka
Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms // Phlebolymphology, 19 (2012), 72-83 (podatak o recenziji nije dostupan, članak, stručni)
Lenković, M., Stanić-Žgombić, Z., Manestar Blažić, T., Brajac, i. & Periša, D. (2012) Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms. Phlebolymphology, 19, 72-83.
@article{article, author = {Lenkovi\'{c}, Maja and Stani\'{c}-\v{Z}gombi\'{c}, Zrinka and Manestar Bla\v{z}i\'{c}, Teo and Brajac, ines and Peri\v{s}a, Darinka}, year = {2012}, pages = {72-83}, keywords = {benefit, Daflon, chronic venous disease}, journal = {Phlebolymphology}, volume = {19}, issn = {1286-0107}, title = {Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms}, keyword = {benefit, Daflon, chronic venous disease} }
@article{article, author = {Lenkovi\'{c}, Maja and Stani\'{c}-\v{Z}gombi\'{c}, Zrinka and Manestar Bla\v{z}i\'{c}, Teo and Brajac, ines and Peri\v{s}a, Darinka}, year = {2012}, pages = {72-83}, keywords = {benefit, Daflon, chronic venous disease}, journal = {Phlebolymphology}, volume = {19}, issn = {1286-0107}, title = {Benefit of Daflon 500 mg in the reduction of chronic venous disease-related symptoms}, keyword = {benefit, Daflon, chronic venous disease} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Emerging Sources Citation Index (ESCI)
  • Scopus


Uključenost u ostale bibliografske baze podataka::


  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font